Hospital or health organisation · founded 1953
Oklahoma City VA Medical Center
Oklahoma City, United States · oklahoma.va.gov/locations/directions.asp
- Citations, last 5 years
- 4 301
- Works, last 5 years
- 470
- h-index
- 184
- Scientists listed
- 0
- Grants since 2016
- 152
Grants received
2025–2029 · grant · I01
Cell-autonomous regulation of microglial reactivity with aging and Alzheimer's Disease
Willard M Freeman · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2025–2029 · grant · I01
BCCMA: Recovery of Aged Muscle After Disuse Atrophy (REMEDY): Targeting energetics and proteostasis in recovery from disuse atrophy
Sue C Bodine · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2025–2029 · grant · I01
Effect of Necroptosis in Neurons on Neuroinflammation, Neuronal Function, and Cognition.
Arlan G. Richardson · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2025–2030 · grant · IK6
BLRD Research Career Scientist Award Application
Benjamin Francis Miller · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2024–2025 · grant · I01
DEI Summer Research Program
Robert Hal Scofield · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2023–2024 · grant · IS1
ShEEP Request for Iterative Imaging System (MACSima)
Willard M Freeman · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2023–2027 · grant · I01
Procoagulant platelets as biomarkers for post-COVID-19 cognitive decline
Angelia Kirkpatrick · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2023–2027 · grant · I01
Procoagulant platelets as biomarkers for post-COVID-19 cognitive decline
Angelia Kirkpatrick · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2023 · grant · IS1
ShEEP Request for SCANCO microCT
Mary Beth Humphrey · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2023–2027 · grant · I01
Procoagulant platelets as biomarkers for post-COVID-19 cognitive decline
Angelia Kirkpatrick · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2027 · grant · IK6
BLRD Research Career Scientist Award Application
Willard M Freeman · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2026 · grant · IK2
Lipid hydroperoxides in sarcopenia and muscle wasting: mechanisms and intervention
Jacob Levi Brown · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2027 · grant · IK6
BLRD Research Career Scientist Award Application
Veronica Galvan · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2027 · grant · IK6
BLRD Research Career Scientist Award Application
Willard M Freeman · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2025 · grant · I01
Sarcopenia and recovery from Disuse-Induced Atrophy
Sue C Bodine · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2027 · grant · IK6
BLRD Research Career Scientist Award Application
Veronica Galvan · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2026 · grant · I01
Mechanism through which chronically elevated mTOR activity impairs aged muscle recovery after disuse atrophy
Benjamin Francis Miller · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2026 · grant · I01
BCCMA: Targeting Osteoarthritis Pain and Progression: Preclinical OA models of vagal nerve stimulation to reduce pain and progression of OA
Mary Beth Humphrey · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2026 · grant · IK2
Lipid hydroperoxides in sarcopenia and muscle wasting: mechanisms and intervention
Jacob Levi Brown · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2026 · grant · I01
Mechanism through which chronically elevated mTOR activity impairs aged muscle recovery after disuse atrophy
Benjamin Francis Miller · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2026 · grant · I01
Mechanism through which chronically elevated mTOR activity impairs aged muscle recovery after disuse atrophy
Benjamin Francis Miller · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2027 · grant · I01
Cartilage Microbial Products as Novel Drivers of Knee Osteoarthritis Epigenetic Dysregulation
Matlock Jeffries · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2026 · grant · I01
Sarcopenia and recovery from Disuse-Induced Atrophy
Sue C Bodine · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2027 · grant · IK6
BLRD Research Career Scientist Award Application
Veronica Galvan · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2027 · grant · IK6
BLRD Research Career Scientist Award Application
Willard M Freeman · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2027 · grant · I01
BCCMA: Targeting Osteoarthritis Pain and Progression: Preclinical OA models of vagal nerve stimulation to reduce pain and progression of OA
Mary Beth Humphrey · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2026 · grant · IK2
Lipid hydroperoxides in sarcopenia and muscle wasting: mechanisms and intervention
Jacob Levi Brown · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2026 · grant · I01
Cartilage Microbial Products as Novel Drivers of Knee Osteoarthritis Epigenetic Dysregulation
Matlock Jeffries · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2027 · grant · IK6
BLRD Research Career Scientist Award Application
Veronica Galvan · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2026 · grant · I01
Mechanism through which chronically elevated mTOR activity impairs aged muscle recovery after disuse atrophy
Benjamin Francis Miller · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2025 · grant · IK2
Lipid hydroperoxides in sarcopenia and muscle wasting: mechanisms and intervention
Jacob Levi Brown · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2027 · grant · I01
Cartilage Microbial Products as Novel Drivers of Knee Osteoarthritis Epigenetic Dysregulation
Matlock Jeffries · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2027 · grant · IK6
BLRD Research Career Scientist Award Application
Willard M Freeman · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2026 · grant · I01
Sarcopenia and recovery from Disuse-Induced Atrophy
Sue C Bodine · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2022–2027 · grant · I01
BCCMA: Targeting Osteoarthritis Pain and Progression: Preclinical OA models of vagal nerve stimulation to reduce pain and progression of OA
Mary Beth Humphrey · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2021–2025 · grant · I01
Plasticity of GABA input to VTA dopamine neurons in opioid use disorders
Michael J Beckstead · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2021–2023 · grant · I21
Testing OKN-007 as a potential intervention for ALS
Holly Van Remmen · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2021–2025 · grant · I01
Targeting GCNT3 for Pancreatic Cancer
Chinthalapally V. Rao · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2021–2023 · grant · I21
Testing OKN-007 as a potential intervention for ALS
Holly Van Remmen · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs
2021–2025 · grant · I01
Plasticity of GABA input to VTA dopamine neurons in opioid use disorders
Michael J Beckstead · Oklahoma City VA Medical Center · funded by U.S. Department of Veterans Affairs